CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cryoport, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$16.98+0.14 (+0.83%)
Close on Oct 19, 2026
- Market cap
- $856.52M
- P/E (TTM)
- –
- Dividend yield
- –
Cryoport statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Cryoport | Industry median |
|---|---|---|
| Market Cap | $860.02M | $166.30M |
| Enterprise Value | $464.31M | $88.19M |
| PS Ratio | 4.61 | 3.65 |
| PB Ratio | 1.75 | 2.03 |
| P/TBV Ratio | 2.59 | 2.29 |
| P/OCF Ratio | 107.87 | 12.98 |
Enterprise value
| Measure | Cryoport | Industry median |
|---|---|---|
| EV / Sales | 2.49 | 2.51 |
Income (trailing twelve months)
| Measure | Cryoport | Industry median |
|---|---|---|
| Revenue | $186.45M | $58.34M |
| Gross Profit | $87.77M | $105.94M |
| Operating Income | -$39.62M | -$21.40M |
| Pretax Income | -$31.00M | -$14.34M |
| Net Income | -$37.39M | -$22.46M |
| EBITDA | -$13.86M | -$16.91M |
| EPS (Diluted) | -$0.90 | -$0.83 |
Margins
| Measure | Cryoport | Industry median |
|---|---|---|
| Gross Margin | 47.1% | 52.9% |
| Operating Margin | -21.2% | -44.0% |
| Pretax Margin | -16.6% | -13.3% |
| Profit Margin | -20.1% | -40.2% |
| EBITDA Margin | -7.43% | -30.2% |
| FCF Margin | -10.7% | -9.27% |
Returns
| Measure | Cryoport | Industry median |
|---|---|---|
| Return on Equity (ROE) | -7.40% | -53.2% |
| Return on Assets (ROA) | -4.89% | -40.9% |
| Return on Invested Capital (ROIC) | -33.0% | -32.4% |
| Return on Capital Employed (ROCE) | -7.40% | -38.1% |
Growth
| Measure | Cryoport | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 12.1% | 5.96% |
| Net Income Growth (YoY) | -147.3% | -35.2% |
| EPS Growth (YoY) | -163.8% | -26.2% |
| Revenue Growth (3Y CAGR) | -9.45% | 2.25% |
| Revenue Growth (5Y CAGR) | 17.5% | 6.48% |
Balance sheet
| Measure | Cryoport | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $396.69M | $61.43M |
| Total Debt | $985.00K | $118.52M |
| Net Cash (Debt) | $395.71M | $15.35M |
| Net Cash Per Share | $7.81 | $0.66 |
| Equity (Book Value) | $490.70M | $49.09M |
| Book Value Per Share | $9.69 | $1.37 |
| Tangible Book Value | $332.64M | $23.52M |
| Working Capital | $239.17M | $76.81M |
Financial position
| Measure | Cryoport | Industry median |
|---|---|---|
| Current Ratio | 2.08 | 3.34 |
| Quick Ratio | 1.96 | 2.44 |
| Debt / Equity | 0.00 | 0.52 |
| Interest Coverage | -18.78 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Cryoport | Industry median |
|---|---|---|
| Operating Cash Flow | $7.97M | -$12.35M |
| Capital Expenditures | -$28.00M | -$1.08M |
| Free Cash Flow | -$20.03M | -$20.22M |
| FCF Per Share | -$0.40 | -$0.42 |
Efficiency
| Measure | Cryoport | Industry median |
|---|---|---|
| Asset Turnover | 0.24 | 0.39 |
| Inventory Turnover | 4.43 | 2.70 |
| Revenue Per Employee | $252.65K | $404.87K |
| Profits Per Employee | -$50.66K | -$703.34K |
| Employee Count | 738 | 74 |
Dividends and yields
| Measure | Cryoport | Industry median |
|---|---|---|
| Earnings Yield | -4.35% | -23.3% |
| FCF Yield | -2.33% | -8.72% |
Shares
| Measure | Cryoport | Industry median |
|---|---|---|
| Shares Outstanding | 50,649,100 | 58,127,000 |
| Shares Change (YoY) | 0.60% | 10.9% |
| Shares Change (QoQ) | 0.90% | 0.54% |
| Float | 48,825,100 | 49,136,700 |
| Shares Held by Insiders | 3.60% | 11.6% |
| Shares Held by Institutions | 93.9% | 59.4% |
Taxes
| Measure | Cryoport | Industry median |
|---|---|---|
| Income Tax | $1.90M | $79.87K |
Scores
| Measure | Cryoport | Industry median |
|---|---|---|
| Altman Z-Score | 1.09 | -0.22 |
| Piotroski F-Score | 5 | 4 |
| Beneish M-Score | -2.48 | -2.62 |
Calculated by StockData from Cryoport's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.